ArticleIranian journal of basic medical sciences2026
Impact of TGF-β and ERK1/2 inhibition on preimplantation embryo development and quality.
Article in Iranian journal of basic medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Preimplantation embryo culture is a critical phase in assisted reproductive technologies. The use of small molecules to modulate signaling pathways has emerged as a strategy to improve embryo viability. SB431542 inhibits the TGF-β pathway, while PD0325901 inhibits the MEK/ERK pathway. This study investigates whether their combined application affects embryonic development and cellular composition during early culture, independent of stem cell derivation. Materials and Methods: To assess the effects of SB431542 and PD0325901 on early embryo development, mouse embryos at 2PN, two-cell, and eight-cell stages were collected Results: Embryos treated with SB431542 and PD0325901 showed a slightly higher rate of blastocyst formation than controls, though the difference was not statistically significant. Degeneration and apoptosis rates were also comparable between groups. However, treated embryos exhibited a significant reduction in ICM cells at early stages, suggesting compromised inner cell mass development. These findings indicate that dual inhibition may not enhance embryo quality under the tested conditions. Conclusion: SB431542 and PD0325901, when applied during preimplantation embryo culture, do not significantly improve developmental progression or reduce degeneration and apoptosis. The observed decrease in ICM cells suggests limited benefit for embryo culture protocols designed to support early development. Further studies are needed to evaluate their relevance in stem cell derivation contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.